Clinical Oncology
Volume 19, Issue 8 , Pages 593-595, October 2007

Improving Adjuvant Chemotherapy in Breast Cancer — Can We Get More for Less with TACT2?

  • L. Johnson

      Affiliations

    • Section of Clinical Trials, Institute of Cancer Research, Cotswold Road, Sutton, Surrey SM2 5NG, UK
    • Corresponding Author InformationAuthor for correspondence: L. Johnson, Section of Clinical Trials, Sir Richard Doll Building, Institute of Cancer Research, Cotswold Road, Sutton, Surrey SM2 5NG, UK.
    • ,
  • D. Cameron

      Affiliations

    • University of Leeds, Cookridge Hospital, Leeds L16 6QB, UK and Western General Hospital, Crewe Road, Edinburgh EH4 2XU, UK
    • ,
  • P. Barrett-Lee

      Affiliations

    • Velindre Hospital, Whitchurch, Cardiff CF4 7XL, UK
    • ,
  • P. Canney

      Affiliations

    • Beatson Oncology Centre, Western Infirmary, Glasgow G11 6NT, UK
    • ,
  • J.M. Bliss

      Affiliations

    • Section of Clinical Trials, Institute of Cancer Research, Cotswold Road, Sutton, Surrey SM2 5NG, UK
    • ,
  • on behalf of the TACT2 Trial Management Group

Received 5 June 2007; accepted 26 June 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0936-6555(07)00690-5

doi:10.1016/j.clon.2007.06.016

Clinical Oncology
Volume 19, Issue 8 , Pages 593-595, October 2007

Article Tools

* Image Usage & Resolution